4/A//SEC Filing
Arnold Susan Elizabeth 4/A
Accession 0001169245-21-000089
CIK 0001169245other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:43 PM ET
Size
7.3 KB
Accession
0001169245-21-000089
Insider Transaction Report
Form 4/AAmended
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-12−4,519→ 0 totalExercise: $1.74From: 2015-07-12Exp: 2021-07-12→ Common Stock (4,519 underlying) - Exercise/Conversion
Common Stock
2021-07-12$1.74/sh+4,519$7,863→ 27,760 total
Footnotes (3)
- [F1]Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on July 12, 2021.
- [F2]Amended to add a transaction for the exercise of stock options on July 12, 2021.
- [F3]All shares underlying this option have vested.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755746
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:43 PM ET
- Size
- 7.3 KB